ArticleCA: a cancer journal for clinicians
Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.
Article in CA: a cancer journal for clinicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 32 citations in OpenAlex.
- Diving Into the Gray Zone: A Patient Perspective on What Patient-Centered DCIS Care Really Means.Journal of patient experience · 2026Article
- Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study.Annals of surgical oncology · 2025Article
- Risk perception of patients with ductal carcinomaHistology and histopathology · 2025Review
- Labels, Language, and Other Strategies to Improve Communication About Lower Grade Forms of Ductal Carcinoma In Situ of the Breast: A National Delphi Survey.International journal of breast cancer · 2025Article
- Article
- Comparison of the ductal carcinoma in situ between White Americans and Chinese Americans.Medicine · 2021Observational
- Recommendations to improve patient-centred care for ductal carcinoma in situ: Qualitative focus groups with women.Health expectations : an international journal of public participation in health care and health policy · 2020Article
- Quality of DCIS information on the internet: a content analysis.Breast cancer research and treatment · 2019Review
- Ductal carcinoma in situ: to treat or not to treat, that is the question.British journal of cancer · 2019Review
- National consensus recommendations on patient-centered care for ductal carcinoma in situ.Breast cancer research and treatment · 2019Review
- Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.International journal of nanomedicine · 2019Article
- Interventions are needed to support patient-provider decision-making for DCIS: a scoping review.Breast cancer research and treatment · 2018Article
- Mammography, Martin Yaffe, and me: response and appreciation.Current oncology (Toronto, Ont.) · 2015Article
- Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.Journal of the National Cancer Institute · 2015Article
- Estimates of young breast cancer survivors at risk for infertility in the U.S.The oncologist · 2014Article
- A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer.Current oncology (Toronto, Ont.) · 2014Article
- Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.Breast cancer research and treatment · 2013Article
- Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study.Current oncology (Toronto, Ont.) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
Abstract
In September 2010, the American Cancer Society and National Cancer Institute convened a conference to review current issues in ductal carcinoma in situ (DCIS) risk communication and decision-making and to identify directions for future research. Specific topics included patient and health care provider knowledge and attitudes about DCIS and its treatment, how to explain DCIS to patients given the heterogeneity of the disease, consideration of nomenclature changes, and the usefulness of decision tools/aids. This report describes the proceedings of the workshop in the context of the current literature and discusses future directions. Evidence suggests that there is a lack of clarity about the implications and risks of a diagnosis of DCIS among patients, providers, and researchers. Research is needed to understand better the biology and mechanisms of the progression of DCIS to invasive breast cancer and the factors that predict those subtypes of DCIS that do not progress, as well as efforts to improve the communication and informed decision-making surrounding DCIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.